Stéphane Bergeron at the Foreign Affairs and International Development Committee

Thank you, Mr. Chair.

I'd like some clarification. In response to Mr. Chong's question earlier, Mr. Tabah suggested that Canada's financial contribution to COVAX consisted in supplying the equivalent of a certain number of vaccine doses.

Does that mean that the bulk of Canada's financial contribution to COVAX will be used to purchase doses and that no part of the contribution will go towards addressing the new challenge of distributing and administering doses in recipient countries?